Wang Yan, Wang Lina, Yu Xue, Duan Jianping
Chronic Disease Management Center, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province 266033, People's Republic of China.
Department of Clinical Lab, Qingdao Sixth People's Hospital, Qingdao City, Shandong Province 266033, People's Republic of China.
Onco Targets Ther. 2019 Jul 1;12:5069-5076. doi: 10.2147/OTT.S203206. eCollection 2019.
This study was designed to explore the regulation mechanism of miR-450 in the development of hepatocarcinoma, and the effects of overexpression of miR-450 on biological behaviors such as proliferation, migration, and invasion of hepatoma cells.
HepG2 cells were divided into miR-450 mimics group, miR-450 inhibitor group, miR-450 mimics NC group, miR-450 inhibitor NC group, and blank group. MTT assay was served to measure cell proliferation, and Transwell assay was used to test cell migration and invasion. Additionally, cell cycle was detected by flow cytometry and apoptosis was examined with AnnexinV-PI double staining. After the target gene of miR-450 was predicted by bioinformatics software, Western blot and dual luciferase reporter gene experiment were applied to verify the relationship between miR-450 and target gene.
The MTT and Transwell assay indicated that overexpression of miR-450 inhibited the proliferation, invasion, and migration of HepG2 cells. The flow cytometry analysis showed that overexpression of miR-450 arrested the cell cycle in the G1 phase. Meanwhile, Annexin V-PI double staining assay revealed that overexpression of miR-450 promoted apoptosis of HepG2 cells. However, silencing miR-450 in HepG2 cells promoted proliferation and invasion, and reduced apoptosis. Moreover, we found that DNMT3a was the target gene of miR-450.
miR-450 could inhibit proliferation, invasion, and migration via regulating DNMT3a in hepatocarcinoma cells, which provided a theoretical basis for the treatment of liver cancer.
本研究旨在探讨miR - 450在肝癌发生发展中的调控机制,以及miR - 450过表达对肝癌细胞增殖、迁移和侵袭等生物学行为的影响。
将HepG2细胞分为miR - 450模拟物组、miR - 450抑制剂组、miR - 450模拟物阴性对照组、miR - 450抑制剂阴性对照组和空白组。采用MTT法检测细胞增殖,Transwell法检测细胞迁移和侵袭。此外,通过流式细胞术检测细胞周期,用AnnexinV - PI双染法检测细胞凋亡。利用生物信息学软件预测miR - 450的靶基因后,采用蛋白质免疫印迹法和双荧光素酶报告基因实验验证miR - 450与靶基因的关系。
MTT和Transwell实验表明,miR - 450过表达抑制了HepG2细胞的增殖、侵袭和迁移。流式细胞术分析显示,miR - 450过表达使细胞周期停滞在G1期。同时,Annexin V - PI双染实验表明,miR - 450过表达促进了HepG2细胞的凋亡。然而,沉默HepG2细胞中的miR - 450可促进细胞增殖和侵袭,并减少细胞凋亡。此外,我们发现DNMT3a是miR - 450的靶基因。
miR - 450可通过调控DNMT3a抑制肝癌细胞的增殖、侵袭和迁移,为肝癌治疗提供了理论依据。